Considering the debated role of KDM5C as an oncogene or tumor suppressor and its crucial contribution in brain functioning, we first aimed to establish KDM5C expression levels by real time PCR (RT-PCR) in tumor samples (N = 37) derived from GBM patients compared to brain control samples (N = 8). This evidence concerns the gene KDM5C and glioblastoma.